Our multidisciplinary team evaluates and treats patients with suspected or diagnosed multiple sclerosis (MS). MS is a chronic central nervous system disease that causes symptoms ranging from numbness to weakness. Up to 10% of MS patients are diagnosed before the age of 18. The disease has different effects in these younger patients whose brains are still developing.
We are dedicated to research to advance the field of MS treatment. Our program receives funding from Race to Erase MS, and we offer clinical trials for MS therapies that are designed for children.